Oxime
| Reactivator name | Formula | Structure |
|---|---|---|
| K107 |
C20H20Br2N4O2 |
|
| K108 |
C20H20Br2N4O2 |
|
| 1-hexyl-2-((hydroxyimino)methyl)pyridinium-Cpd5 |
C13H21N2 |
methyl)pyridinium-Cpd5.gif)
|
| Olesoxime |
C27H45NO |
|
| LG-Cpd55 |
C16H25N5O4 |
|
| LG-804 |
C15H28N6O4 |
|
| JDS364 |
C19H20N4O2 |
|
| 6-Alkyl-3-Fluoro-2-pyridinaldoxime-12d |
C13H12FN3O |
|
| Oxime-20 |
C23H25N2O3+ |
|
| 4-methyl-3-nitrobenzamido-pentyl-PAM-7d |
C19H23N4O4 |
|
| 7P1P-4IX |
C21H31N5O8 |
|
| 7P1N-4J1 |
C22H33N5O8 |
|
| PCM-0212399 |
C6H7N3O2 |
|
| PCM-0211955 |
C7H6BrNO2 |
|
| PCM-0211338 |
C14H14N4O2 |
|
| PCM-0211088 |
C14H14N2O2 |
|
| CBIO |
C15H17ClN3O |
|
| K869 |
C16H19Br2ClN4O2 |
|
| K1374 |
C26H28N4O22+ |
|
| K1375 |
C17H22N4O32+ |
|
| Cl-HIN |
C8H5ClN2O2 |
|
| Triple-binding-oxime-III |
C18H21N7O2 |
|
| Triple-binding-oxime-III-R |
C18H22N8O2 |
|
| Q8-Quinuclidine-3-oxime |
C14H18Br2N2O |
|
| Triazole-annulated-oxime-3A |
C19H22N7O2 |
|
| Triazole-annulated-oxime-2A |
C19H22N5O |
|
| Triazole-annulated-oxime-14A |
C17H19N7O2 |
|
| ADOC-3I |
C11H16N2O |
|
| QMP-1b |
C11H18N2O2 |
|
| QMP-10c |
C19H21N3O4 |
|
| QMP-C8 |
C10H14N2O |
|
| ADOC |
C11H18N2O |
|
| Amodiaquine |
C20H22ClN3O |
|
| 7-MEOTA-4-pyridinealdoxime |
C25H33BrN4O2 |
|
| MINA |
C3H5NO2 |
|
| L10R1 |
C18H22N4O |
|
| SP-138 |
C22H19BrN4O |
|
| SP-134 |
C14H16Cl2N2O |
|
| MB442 |
C15H20N2+2 |
|
| MB327 |
C21H3N2O |
|
| SAD-128 |
C20H30Cl2N2O |
|
| Propane-bis-methyloxime-isoquinolinium-cpd17 |
C23H22Br2N4O2 |
|
| 2BIM-7 |
C15H26N6O2 |
|
| Ortho-7 |
C19H26N4O2-2+ |
|
| K005 |
C15H18N4O2 || C15H18N4O2+2 |
|
| K131 |
C19H21Br2N3O || C19H21N3O |
|
| K142 |
C19H21Br2N3O |
|
| K153 |
C15H19Br2N3O |
|
| K454 |
C20H21Br2N3O |
|
| K456 |
C16H19Br2N3O2 |
|
| K458 |
C15H19Br2N5O2 |
|
| K727 |
C24H22Br2N4O2 |
|
| K733 |
C22H24Br2N3O3 |
|
| K117 |
C16H20N4O3+2 |
|
| K127 |
C16H20Br2N4O3 |
|
| K1833 |
C26H28BBr2F2N7O2 |
|
| K027-Cl2 |
C15H16Cl2N4O2+ |
|
| K027 |
C15H18N4O2 |
|
| K033 |
C16H20N4O2 |
|
| K048 |
C16H20N4O2 |
|
| K206 |
C16H17N4O2 |
|
| K870 |
C16H16Cl2N4O2 |
|
| K203 |
C16H18N4O2 |
|
| K074 |
C14H16N4O2+2 |
|
| K075 |
C16H18N4O2 |
|
| K156 |
C14H17N3O |
|
| LG-703 |
C13H24N6O4 |
|
| LG-1922 |
C14H25N5O4 |
|
| LLNL-02 |
C15H21N3O2 |
|
| RS194B |
C10H19N3O2 |
|
| RS170B |
C13H16N5O2 |
|
| TAB2OH |
C10H15ClN2O2 |
|
| Tryptoline-hydroxy-pyridinaldoxime-3 |
C21H24N4O2 |
|
| Phenyltetrahydroisoquinoline-Pyridinaldoxime-1b |
C27H31N3O4 |
|
| Phenyltetrahydroisoquinoline-Pyridinaldoxime-1c |
C28H33N3O4 |
|
| Tryptoline-hydroxy-pyridinaldoxime-4 |
C22H26N4O2 |
|
| JR585 |
C16H25N3O2 |
|
| JR595 |
C14H21N3O3 |
|
| GM415 |
C22H29N3O4 |
|
| GM508 |
C30H39N4O4 |
|
| RM048 |
C15H23N3O3 |
|
| 2-PAM |
C7H9N2O |
|
| PAM |
C6H6N2O |
|
| 3-PAM |
C7H9N2O |
|
| 4-PAM |
C7H9N2O |
|
| BDB-106 |
C14H20N6O2 |
|
| BDB-108 |
C16H18Br2N4O2 |
|
| BDB-110 |
C14H22N6O2 |
|
| ICD-467 |
C11H19ClN4O4 |
|
| BI-6 |
C16H18N4O2 |
|
| Benzyl-P2A |
C13H13ClN2O |
|
| DAM |
C4H7NO2 |
|
| HGG-12 |
C20H19I2N3O3 |
|
| HGG-21 |
C15H17I2N3O3 |
|
| HGG-42 |
C20H25I2N3O3 |
|
| HGG-52 |
C19H25Cl2N3O3 |
|
| HI-6 |
C14H16Cl2N4O3 || C16H22N4O9S2 |
|
| HLo-7 |
C15H17I2N5O4 |
|
| HS-3 |
C14H16Cl2N4O3 |
|
| HS-6 |
C14H16Cl2N4O3 |
|
| DMB-4 |
C14H16N4O2+2 |
|
| MMB-4 |
C13H14Br2N4O2 |
|
| P2s~contrathion |
C7H9IN2O |
|
| Tacrine-pyridinealdoxime-1 |
C23H27N4O2 |
|
| Tacrine-pyridinealdoxime-2 |
C23H25ClN4O2 |
|
| pro-2PAM |
C7H11ClN2O |
|
| R665 |
C17H22I2N4O4 |
|
| Trimedoxime |
C15H18Br2N4O2 |
|
| Toxogonin |
C14H16Cl2N4O3 |
|